Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hemangioma, Cavernous, Central Nervous System × Atorvastatin × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Smoking 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Ototoxicity 1 Neoplastic Cells, Circulating 1 Hemangioma, Cavernous, Central Nervous System 1 Heart Failure 1 Hearing Loss 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colorectal Neoplasms 1 Colitis, Ulcerative 1 Cardiotoxicity 1 Carcinoma, Squamous Cell 1

Interventions

daratumumab 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02603328 2025-08-22

AT CASH EPOC

University of Chicago

Phase 1/2 Completed

80 enrolled 19 charts

Hemangioma, Cavernous, Central Nervous System

Data powered by HemOnc (CC BY 4.0) Colophon ⚡